These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36425571)

  • 1. The effect of
    Said SA; Abdulbaset A; El-Kholy AA; Besckales O; Sabri NA
    Front Pharmacol; 2022; 13():1011522. PubMed ID: 36425571
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19-Results From a Pilot Open-Label, Randomized Controlled Trial.
    Khan A; Iqtadar S; Mumtaz SU; Heinrich M; Pascual-Figal DA; Livingstone S; Abaidullah S
    Front Pharmacol; 2022; 13():898062. PubMed ID: 35747751
    [No Abstract]   [Full Text] [Related]  

  • 4. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Honey and Nigella sativa against COVID-19 in Pakistan (HNS-COVID-PK): A multicenter placebo-controlled randomized clinical trial.
    Ashraf S; Ashraf S; Ashraf M; Imran MA; Kalsoom L; Siddiqui UN; Farooq I; Akmal R; Akram MK; Ashraf S; Ghufran M; Majeed N; Habib Z; Rafique S; -Abdin ZU; Arshad S; Shahab MS; Ahmad S; Zheng H; Mirza AR; Zulfiqar S; Anwar MI; Humayun A; Mahmud T; Saboor QA; Ahmad A; Ashraf M; Izhar M;
    Phytother Res; 2023 Feb; 37(2):627-644. PubMed ID: 36420866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
    Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA
    Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nigella sativa for the treatment of COVID-19: An open-label randomized controlled clinical trial.
    Koshak AE; Koshak EA; Mobeireek AF; Badawi MA; Wali SO; Malibary HM; Atwah AF; Alhamdan MM; Almalki RA; Madani TA
    Complement Ther Med; 2021 Sep; 61():102769. PubMed ID: 34407441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Short Treatment with Nigella Sativa on Symptoms, the Cluster of Differentiation (CD) Profile, and Inflammatory Markers in Mild COVID-19 Patients: A Randomized, Double-Blind Controlled Trial.
    Bin Abdulrahman KA; Bamosa AO; Bukhari AI; Siddiqui IA; Arafa MA; Mohsin AA; Althageel MF; Aljuaeed MO; Aldeailej IM; Alrajeh AI; Aldosari KM; Hawsawi NA; Zawbaee KI; Alsurayea SM
    Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36142070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
    Irvani SSN; Golmohammadi M; Pourhoseingholi MA; Shokouhi S; Darazam IA
    Trials; 2020 Jun; 21(1):473. PubMed ID: 32493468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic potential of honey and Nigella sativa L. against hospital and community-based SARS-CoV-2 spread: a structured summary of a study protocol for a randomised controlled trial.
    Ashraf S; Ashraf S; Akmal R; Ashraf M; Kalsoom L; Maqsood A; Imran MA; Farooq I; Ashraf S; Siddiqui UN; Ghufran M; Akram MK; Majeed N; Rafique S; Habib Z; Shahab MS; Akmal A; Shaukat Z; Abdin ZU; Khaqan A; Arshad S; Rehman Virk MA; Gul M; Awais AB; Hassan M; Khalid N; Iqbal QUA; Ahmad T; Akram M; Muhammad A; Khalil M; Aslam A; Umer M; Sherazi SSH; Safdar Z; Ahmad S; Bilal M; Zahid MN; Koshak AE; Hilal A; Malik AA; Iqbal U; Baig AA; Alahmadi YM; Humayun A; Malik A; Ahmad A; Ashraf M; Saboor QA; Izhar M;
    Trials; 2021 Sep; 22(1):618. PubMed ID: 34526081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19: A structured summary of a study protocol for a randomized controlled l trial.
    Alavi Darazam I; Hatami F; Rabiei MM; Pourhoseingholi MA; Moradi O; Shokouhi S; Hajesmaeili MR; Shabani M; Irvani SSN
    Trials; 2020 Oct; 21(1):880. PubMed ID: 33106183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial.
    Aricò E; Castiello L; Bracci L; Urbani F; Lombardo F; Bacigalupo I; Ancidoni A; Vanacore N; Falcione A; Reggiani C; Dutti GM; Maglie MG; Papa O; Bartoletti PL; Ozzella G; Bevilacqua N; Nicastri E; Belardelli F; Sconocchia G
    Trials; 2021 Sep; 22(1):584. PubMed ID: 34479601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: Multicentre randomized controlled clinical trial.
    Mariani J; Antonietti L; Tajer C; Ferder L; Inserra F; Sanchez Cunto M; Brosio D; Ross F; Zylberman M; López DE; Luna Hisano C; Maristany Batisda S; Pace G; Salvatore A; Hogrefe JF; Turela M; Gaido A; Rodera B; Banega E; Iglesias ME; Rzepeski M; Gomez Portillo JM; Bertelli M; Vilela A; Heffner L; Annetta VL; Moracho L; Carmona M; Melito G; Martínez MJ; Luna G; Vensentini N; Manucha W
    PLoS One; 2022; 17(5):e0267918. PubMed ID: 35622854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of Siddha Medicine, Kabasura Kudineer (KSK) compared to Vitamin C & Zinc (CZ) supplementation in the management of asymptomatic COVID-19 cases: A structured summary of a study protocol for a randomised controlled trial.
    Natarajan S; Anbarasi C; Sathiyarajeswaran P; Manickam P; Geetha S; Kathiravan R; Prathiba P; Pitchiahkumar M; Parthiban P; Kanakavalli K; Balaji P
    Trials; 2020 Oct; 21(1):892. PubMed ID: 33109252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial.
    Sharma A; Sharma C; Raina S; Singh B; Dadhwal DS; Dogra V; Gupta S; Bhandari S; Sood V
    Trials; 2021 Jul; 22(1):451. PubMed ID: 34266452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Active Compounds of Nigella sativa in COVID-19: A Narrative Review.
    H U; S M; A A; Pk M; R K; R D; D S; Aa M; Panda PK
    Recent Adv Antiinfect Drug Discov; 2023 Feb; ():. PubMed ID: 36815641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial (CARED-TRIAL).
    Mariani J; Tajer C; Antonietti L; Inserra F; Ferder L; Manucha W
    Trials; 2021 Feb; 22(1):111. PubMed ID: 33522946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of vitamins A, B, C, D, and E supplementation on improvement and mortality rate in ICU patients with coronavirus-19: a structured summary of a study protocol for a randomized controlled trial.
    Beigmohammadi MT; Bitarafan S; Hoseindokht A; Abdollahi A; Amoozadeh L; Mahmoodi Ali Abadi M; Foroumandi M
    Trials; 2020 Jul; 21(1):614. PubMed ID: 32631405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.